3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
17
Neoplasm Metastasis
6
Ovarian Neoplasms
5
Endometrial Neoplasms
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Recurrence
2
Pancreatic Neoplasms
2
Neoplasms
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Liposarcoma
2
Glioma
2
Carcinoma, Renal Cell
2
von Hippel-Lindau Disease
1
Xanthogranuloma, Juvenile
1
Wilms Tumor
1
Uterine Neoplasms
1
Urinary Bladder Neoplasms
1
Unilateral Breast Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Interventions
pertuzumab
2
Trastuzumab
2
Taxes
2
Standard of Care
2
Practice Guidelines as Topic
2
Paclitaxel
2
High-Energy Shock Waves
2
Docetaxel
2
trastuzumab biosimilar HLX02
1
Transcutaneous Electric Nerve Stimulation
1
Specimen Handling
1
Radiation Dose Hypofractionation
1
PF-05280014
1
Ontruzant
1
Ogivri
1
Minoxidil
1
Methods
1
Magnetic Resonance Spectroscopy
1
Immunoglobulin G
1
Educational Status
1
Early Intervention, Educational
1
Disulfides
1
Carboplatin
1
Biopsy
1
2C4 antibody
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anatomic Stage I Breast Cancer AJCC v8
×
palbociclib
×
30 days
×
Clear all
No trials found.